Effect of Smoking on Reversing Neuromuscular Block

Basit Öğe Kaydı
dc.contributor.authorÖztürk, Ömür
dc.contributor.authorSezen, Gülbin Yalçın
dc.contributor.authorAnkaralı, Handan
dc.contributor.authorÖzlü, Onur
dc.contributor.authorDemiraran, Yavuz
dc.contributor.authorAteş, Hakan
dc.contributor.authorDost, Burhan
dc.date.accessioned2020-05-01T09:11:47Z
dc.date.available2020-05-01T09:11:47Z
dc.date.issued2016
dc.departmentDÜ, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümüen_US
dc.descriptionAnkarali, Handan Camdeviren/0000-0002-3613-0523en_US
dc.descriptionWOS: 000386161200011en_US
dc.descriptionPubMed: 27909595en_US
dc.description.abstractObjective: Rocuronium is a non-depolarising, intermediate-acting, monoquaternary amino steroid and was brought into clinical use as a potentially ideal muscle relaxant. Post-operative residual curarisation (PORC) results from the prolonged effects of non-depolarising neuromuscular blocking agents. This is a common problem and seriously affects patient safety. No recent study has investigated the effects of sugammadex on smokers, which is often used to restore neuromuscular block and avoid PORC. This study compares the severity of the effects of sugammadex used for antagonising rocuronium bromide and antagonism durations in smokers and non-smokers. Methods: This randomised, prospective study included 40 patients scheduled for elective surgery and belonging to classes I and II based the American Society of Anesthesiologists classification, who were either smokers for at least 10 years or non-smokers. Patients underwent routine and neuromuscular monitoring. At induction, 2 mg kg(-1) propofol and 1 mcg kg(-1) intravenous fentanyl were applied. After the loss of eyelash reflex, 0.6 mg kg(-1) intravenous rocuronium was administered. Patients were intubated at train of four (TOF) 2. Anaesthesia was continued with 50% O-2 + 50% air and 2% sevoflurane. Rocuronium, 0.15 mg kg(-1), was administered at TOF 2 during the operation. At the end of the operation, 2 mg kg(-1) sugammadex was administered. The times until TOF 0.7, 0.8 and 0.9 were recorded. Results: Intubation time was 132.8 +/- 46.4 s for smokers and 127.6 +/- 32.7 s for non-smokers. After sugammadex administration, the time to TOF 0.7 was 153.3 +/- 54.7 s in smokers and 125 +/- 67.2 s in non-smokers. The times were 178.4 +/- 58.8 and 146.6 +/- 72.6 s for TOF 0.8 and 200.8 +/- 55.8 s and 170.4 +/- 77.8 s for TOF 0.9 in smokers and non-smokers, respectively. Conclusion: Although not statistically significant, the time to reach each TOF was longer for smokers. Larger populations and different perspectives are needed to find if sugammadex use is affected by smoking, which has negative effects on the body.en_US
dc.identifier.doi10.5152/TJAR.2016.97720en_US
dc.identifier.endpage211en_US
dc.identifier.issn2149-0937
dc.identifier.issn2149-276X
dc.identifier.issue4en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage206en_US
dc.identifier.urihttps://doi.org/10.5152/TJAR.2016.97720
dc.identifier.urihttps://hdl.handle.net/20.500.12684/5761
dc.identifier.volume44en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakPubMeden_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherAvesen_US
dc.relation.ispartofTurkish Journal Of Anaesthesiology And Reanimationen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectGeneral anaesthesiaen_US
dc.subjectsugammadexen_US
dc.subjectsmokingen_US
dc.titleEffect of Smoking on Reversing Neuromuscular Blocken_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
5761.pdf
Boyut:
113.15 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Makale Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu